Press Releases

Press Releases

Oxford Global is pleased to share with you the final agenda for the 17th Annual Drug Discovery Leaders Summit, 13-14 June 2016, Hotel Palace Berlin in Germany. With the event now just 6 weeks away, I wanted to remind you that there is still time to secure your place. Are…

Press Releases

Regeneron Pharmaceuticals, Inc. will webcast management presentations as follows:     Bank of America Merrill Lynch Healthcare Conference at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) on Tuesday, May 10, 2016     Barclays 2016 Biopharmaceuticals CEO/CFO Conference Call Series at 11:00 a.m. Eastern Time on Thursday, May 19, 2016  …

Press Releases

TRACT Therapeutics, Inc., a biotechnology company developing personalized regulatory T-cell (Treg) therapy, announced today that it received Food and Drug Administration (FDA) approval to initiate a Phase 2 clinical trial to investigate the efficacy and safety of its novel therapy for kidney transplant recipients. The therapeutic approach, utilizing a patient’s…

Press Releases

Diplomat Pharmacy, Inc., the nation's largest independent specialty pharmacy, announced today that it has signed a definitive agreement to acquire Valley Campus Pharmacy, Inc., doing business as TNH Advanced Specialty Pharmacy ("TNH"), a leading specialty pharmacy that provides individualized patient care, based in Van Nuys, California. In 2015, TNH generated…

Press Releases

Gilead Sciences, Inc. announced that the company’s Board of Directors has declared a cash dividend of $0.47 per share of common stock for the second quarter of 2016. The dividend is payable on June 29, 2016, to stockholders of record at the close of business on June 16, 2016. Future…

Press Releases

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that David Haen, Vice President of Business Development and Investor Relations, will present a corporate update at the Joseph Gunnar and Co. PIONEERS 2016 Investor Conference on Thursday, May 5th at 11:30 a.m. Eastern Time.  The conference…

Press Releases

Sanofi US announced today collaborations with the Duke Clinical Research Institute (DCRI) and, separately, with the Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital. The collaborations are designed to create new tools that will help predict how people living with type 2 diabetes adhere to their…

Press Releases

OPKO Health, Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted OPKO’s resubmission on April 22, 2016 of the New Drug Application (NDA) for RAYALDEE® (calcifediol) for the treatment of secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D…

Press Releases

Adimab LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced independent partnerships with two new companies: iTeos Therapeutics and Kodiak Sciences. Under the terms of each agreement, Adimab will use its proprietary platform to discover and/or optimize antibodies against targets chosen…

Press Releases

Novartis today announced that the US Food and Drug Administration (FDA) has granted three Breakthrough Therapy Designations for Ilaris® (canakinumab) to treat three rare types of Periodic Fever Syndromes, also known as Hereditary Periodic Fevers1. This means Novartis will work closely with the FDA to expedite the regulatory review of…